Newsroom > In the News
In the news
News headlines are articles that reference ResMed's company, people, or business practices.
October 2, 2017Seeking Alpha
ResMed I thought was a great BUY in the $60 per share range, and a good buy at $73. It still is for investors after topping an all-time high price.
September 14, 2017San Diego Business Journal
San Diego-based companies like ResMed and NuVasive Inc. argue the tax stifles research and development, job creation and innovation.
September 12, 2017HME News
The use of CPAP telemonitoring with automated feedback messaging improved 90-day adherence in patients with obstructive sleep apnea, according to a ResMed-supported study published in American Journal of Respiratory and Clinical Care Medicine.
September 5, 2017Parks Associates
Kari Hall, VP, Global Software Services at ResMed, recently spoke with Parks Associates about the future of healthcare. Kari was also a speaker at Parks Associates’ annual Connected Health Summit in San Diego, where she and speakers from 2bPrecise, Kaiser, Qualcomm, and UPMC Insurance Services spoke about the business opportunities available through precision medicine.
August 27, 2017RT Magazine
“Because ALS is a progressive disease, many patients receive NIV via a life support device, like ResMed’s Astral ventilator, which can be utilized throughout the course of the disease," said Denise Hartsell, RRT, RPSGT, Senior Product Manager, Ventilation at ResMed.